ISDA has joined forces with Risk to develop an award for over-the-counter derivatives research as a way to increase understanding of the market. "ISDA is very pleased to work with Risk to develop this new program to encourage and highlight the work of academics and other researchers into the uses, purposes and value of the OTC derivatives markets," ISDA CEO Robert Pickel said. "There is a significant body of work that is being conducted by researchers around the world on these important topics, and our hope is that our program will bring this work to a larger universe of readers."

Related Summaries